Supernus adds epilepsy candidate with $185M Biscayne buyAllbiopro2018-09-15T01:36:31+09:009월 15th, 2018|
Chutes & Ladders—Ex-Gilead CMO Andrew Cheng to lead AkeroAllbiopro2018-09-15T01:36:05+09:009월 15th, 2018|
Bone Therapeutics’ cell therapy hits goal in phase 1/2a, but manufacturing changes slow progressAllbiopro2018-09-15T01:35:37+09:009월 15th, 2018|
Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)Allbiopro2018-09-15T01:33:23+09:009월 15th, 2018|
Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BDAllbiopro2018-09-15T01:32:51+09:009월 15th, 2018|
EMBL Ventures Portfolio Company, ViraTherapeutics Acquired by Boehringer Ingelheim in EUR 210 Million TransactionAllbiopro2018-09-15T01:32:23+09:009월 15th, 2018|
Pall and Aetos Biologics Partner on Biosimilar ManufacturingAllbiopro2018-09-15T01:31:26+09:009월 15th, 2018|
Endogenous Protein May Become a Candidate for Drug DevelopmentAllbiopro2018-09-15T01:30:32+09:009월 15th, 2018|
Gilead, Precision BioSciences to Develop Therapies Against Hep BAllbiopro2018-09-15T01:30:05+09:009월 15th, 2018|
With $140 Million State Incentives, Regeneron Expanding in New York and Adding 1,500 JobsAllbiopro2018-09-14T00:17:02+09:009월 14th, 2018|
Pfizer, Novartis to Close North Carolina Sites Ahead of Hurricane FlorenceAllbiopro2018-09-14T00:16:05+09:009월 14th, 2018|
